Zydelig (Gilead Sciences, Inc.)


Welcome to the PulseAid listing for the Zydelig drug offered from Gilead Sciences, Inc.. This Kinase Inhibitor [EPC],Kinase Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Gilead Sciences, Inc.
NON-PROPRIETARY NAME: idelalisib
SUBSTANCE NAME: IDELALISIB
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Kinase Inhibitor [EPC],Kinase Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2014-07-23
END MARKETING DATE: 0000-00-00


Zydelig HUMAN PRESCRIPTION DRUG Details:

Item DescriptionZydelig from Gilead Sciences, Inc.
LABELER NAME: Gilead Sciences, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 100(mg/1)
START MARKETING DATE: 2014-07-23
END MARKETING DATE: 0000-00-00
PRODUCT ID: 61958-1701_c350baf4-c863-4255-9b90-b387b36ddc0a
PRODUCT NDC: 61958-1701
APPLICATION NUMBER: NDA205858

Other IDELALISIB Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Gilead Sciences, Inc.Zydelig